ID

34476

Beschrijving

Hypofractionated Proton Radiation Therapy for Low and Intermediate Risk Prostate Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT01368055

Link

https://clinicaltrials.gov/show/NCT01368055

Trefwoorden

  1. 17-01-19 17-01-19 -
  2. 27-05-19 27-05-19 -
  3. 15-03-21 15-03-21 - Dr. rer. medic Philipp Neuhaus
Houder van rechten

see on clinicaltrials.gov

Geüploaded op

17 januari 2019

DOI

Voor een aanvraag inloggen.

Licentie

Creative Commons BY-NC 3.0

Model Commentaren :

Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.

Itemgroep Commentaren voor :

Item Commentaren voor :

U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.

Eligibility Prostate Cancer NCT01368055

Eligibility Prostate Cancer NCT01368055

Inclusion Criteria
Beschrijving

Inclusion Criteria

Alias
UMLS CUI
C1512693
prostate cancer.
Beschrijving

ID.1

Datatype

boolean

gleason score 2-6 or 7.
Beschrijving

ID.2

Datatype

boolean

psa ≤ 20 ng/ml.
Beschrijving

ID.3

Datatype

boolean

Exclusion Criteria
Beschrijving

Exclusion Criteria

Alias
UMLS CUI
C0680251
previous prostate cancer surgery or pelvic radiation.
Beschrijving

ID.4

Datatype

boolean

prior/concurrent systemic chemotherapy for prostate cancer.
Beschrijving

ID.5

Datatype

boolean

active inflammatory bowel disease (crohn's disease, diverticulitis or ulcerative colitis) affecting the rectum.
Beschrijving

ID.6

Datatype

boolean

history of hip replacement.
Beschrijving

ID.7

Datatype

boolean

prior intrapelvic surgery.
Beschrijving

ID.8

Datatype

boolean

taking saw palmetto or methotrexate and unable or unwilling to discontinue its uses during radiation.
Beschrijving

ID.9

Datatype

boolean

receiving continuous and current anticoagulation with warfarin sodium (coumadin), clopidogrel bisulfate (plavix), dabigatran etexilate mesylate (pradaxa),enoxaparin sodium (lovenox), or aspirin/er dipyridamole (aggrenox).
Beschrijving

ID.10

Datatype

boolean

Similar models

Eligibility Prostate Cancer NCT01368055

Name
Type
Description | Question | Decode (Coded Value)
Datatype
Alias
Item Group
C1512693 (UMLS CUI)
ID.1
Item
prostate cancer.
boolean
ID.2
Item
gleason score 2-6 or 7.
boolean
ID.3
Item
psa ≤ 20 ng/ml.
boolean
Item Group
C0680251 (UMLS CUI)
ID.4
Item
previous prostate cancer surgery or pelvic radiation.
boolean
ID.5
Item
prior/concurrent systemic chemotherapy for prostate cancer.
boolean
ID.6
Item
active inflammatory bowel disease (crohn's disease, diverticulitis or ulcerative colitis) affecting the rectum.
boolean
ID.7
Item
history of hip replacement.
boolean
ID.8
Item
prior intrapelvic surgery.
boolean
ID.9
Item
taking saw palmetto or methotrexate and unable or unwilling to discontinue its uses during radiation.
boolean
ID.10
Item
receiving continuous and current anticoagulation with warfarin sodium (coumadin), clopidogrel bisulfate (plavix), dabigatran etexilate mesylate (pradaxa),enoxaparin sodium (lovenox), or aspirin/er dipyridamole (aggrenox).
boolean

Gebruik dit formulier voor feedback, vragen en verbeteringsvoorstellen.

Velden gemarkeerd met een * zijn verplicht.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial